Moreover, despite a 300 fold lower in vitro affinity for Syk in comparison to the Syk enzymatic inhibitor R406, C-13 had a stronger inhibitory effect on CRC cell lines viability (Fig 6H). The gene discussed is SYK; the disease is colorectal carcinoma.